# OnCo record novartis-venture-fund (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/novartis-venture-fund/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "novartis-venture-fund" ;
  schema:name "Novartis Venture Fund"@en ;
  schema:description "The Novartis Venture Fund is Novartis's corporate venture arm, run from Basel and Cambridge, Massachusetts, making seed and Series A investments of 5 to 10 million dollars in biotech companies, including the cancer drug developers Artios Pharma, CatalYm and Epsilogen. It manages over 750 million dollars across more than 40 companies."@en ;
  schema:url <https://onco.cc/companies/novartis-venture-fund/>, <https://www.nvfund.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.nvfund.com/>, <https://www.nvfund.com/portfolio> ;
  onco:tag "corporate-venture" ;
  schema:addressCountry "CH" ;
  onco:companies <https://onco.cc/companies/novartis/> .